Morgan Stanley Starts STERIS (STE) at Equalweight, 'Clean bill of health'

Morgan Stanley analyst Patrick Wood initiates coverage on STERIS (NYSE: STE) with a Equalweight rating and a price target of $206.00.

The analyst comments "We think STE is in great shape from a volume and price perspective, and while we see some upside risk later this year on margins, we think much of this is captured in valuation. Initiate at Equal-weight with a PT of $206."

For an analyst ratings summary and ratings history on STERIS click here. For more ratings news on STERIS click here.

Shares of STERIS closed at $200.44 yesterday.

You May Also Be Interested In

• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald
• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'